US Broker Ratings

Mereo BioPharma Group plc (MREO) Stock Analysis: Exploring a Potential 780% Upside in Biotech Innovation

Mereo BioPharma Group plc (NASDAQ: MREO) is a name that has been making waves in the biotechnology sector, offering a striking potential upside of 780% based on its average target..

Zhengye Biotechnology (ZYBT) Stock Report: Navigating Challenges with a $54 Million Market Cap

Zhengye Biotechnology Holding Limited (ZYBT), a key player in the healthcare sector, specifically within the drug manufacturing industry, is currently navigating turbulent waters. The company, headquartered in Jilin, China, focuses..

Harrow, Inc. (HROW) Stock Analysis: Navigating a 28.88% Upside Potential Amidst Robust Revenue Growth

In the bustling world of healthcare investments, Harrow, Inc. (HROW), a prominent player in the specialty and generic drug manufacturing sector, is garnering significant attention. With its focus on ophthalmic..

agilon health, inc. (AGL) Stock Analysis: Navigating Challenges with a 39% Potential Upside

The healthcare industry often stands at the forefront of investor discussions due to its essential role in society and potential for innovation-driven growth. Among the intriguing players in this sector..

Viridian Therapeutics, Inc. (VRDN) Investor Outlook: Exploring a Potential 36.59% Upside in the Biotech Arena

With its roots firmly planted in the biotechnology industry, Viridian Therapeutics, Inc. (NASDAQ: VRDN) is making waves, particularly in the treatment of serious and rare diseases. As the company advances..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: A 24% Upside Potential Amidst Strong Buy Ratings

Investors keeping an eye on the healthcare sector, particularly the medical devices industry, might find Establishment Labs Holdings Inc (NASDAQ: ESTA) a compelling prospect. Headquartered in Alajuela, Costa Rica, this..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: A Healthcare Gem with 38.89% Upside Potential

ANI Pharmaceuticals, Inc. (ANIP) has positioned itself as a noteworthy player in the healthcare sector, particularly within the drug manufacturing space, focusing on both specialty and generic products. With its..

Mesoblast Limited (MESO) Stock Report: Exploring a 91.36% Potential Upside

Investors looking for opportunities in the biotechnology sector might find Mesoblast Limited (NASDAQ: MESO) an intriguing prospect. As an Australian-based leader in regenerative medicine, Mesoblast is making strides with its..

Innoviva, Inc. (INVA) Stock Report: Exploring a 62% Upside Potential

Innoviva, Inc. (NASDAQ: INVA), a key player in the biotechnology sector of the healthcare industry, is attracting attention from investors due to its impressive potential upside of 62.26%. With a..

Evolent Health, Inc. (EVH) Stock Analysis: Can a 155% Upside Propel This Healthcare Innovator?

Evolent Health, Inc. (NASDAQ: EVH), a key player in the health information services sector, has been on the radar of investors due to its innovative approach to healthcare management and..

Ocular Therapeutix, Inc. (OCUL) Investor Outlook: Unpacking the 109% Potential Upside

Ocular Therapeutix, Inc. (OCUL), a prominent player in the biotechnology sector, has recently caught the attention of investors with its ambitious pipeline and significant market potential. Based in Bedford, Massachusetts,..

NeoGenomics, Inc. (NEO) Investor Outlook: Diagnostic Leader with 18% Upside Potential

NeoGenomics, Inc. (NASDAQ: NEO) stands at the forefront of the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $1.56 billion, NeoGenomics operates a robust..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Exploring a 71.61% Upside Potential

GoodRx Holdings, Inc. (NASDAQ: GDRX) is capturing attention in the healthcare sector with its innovative approach to prescription drug pricing and a significant potential upside of 71.61% according to analyst..

Mineralys Therapeutics, Inc. (MLYS) Investor Outlook: Analyzing a Potential 42.67% Upside in the Biotech Sector

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is capturing investor attention within the healthcare sector, specifically in biotechnology, thanks to its promising developments and potential upside. With a market capitalization of $2.82..

Wave Life Sciences Ltd. (WVE) Stock Analysis: A Biotech Innovator with Over 110% Potential Upside

Wave Life Sciences Ltd. (NASDAQ: WVE), a Singapore-based clinical-stage biotechnology company, is capturing investor attention with its promising pipeline of RNA medicines and a remarkable potential upside of 110.67%, according..

GRAIL, Inc. (GRAL) Stock Analysis: Eyeing a 9.66% Upside with Innovative Cancer Detection

GRAIL, Inc. (NASDAQ: GRAL) is carving out a significant niche within the Healthcare sector, particularly in the Diagnostics & Research industry. With a market capitalization of $3.73 billion, this Menlo..

Evotec SE (EVO): Investor Outlook on a Potential 74.5% Upside Amid Challenging Metrics

Evotec SE (EVO), a prominent player in the healthcare sector, stands out as a multifaceted drug discovery and development company with a global footprint spanning the United States, Europe, and..

Kiniksa Pharmaceuticals, Ltd. (KNSA) Stock Analysis: Exploring a 33% Upside Potential with Robust Growth Metrics

Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) is gaining attention in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a current market capitalization of $3.11 billion and..

Dynavax Technologies Corporation (DVAX) Investor Outlook: Assessing the 33% Upside Potential

Investors with a keen eye on the healthcare sector might find Dynavax Technologies Corporation (NASDAQ: DVAX) an intriguing prospect. As a commercial-stage biopharmaceutical company, Dynavax is at the forefront of..

BioLife Solutions, Inc. (BLFS) Stock Analysis: 28% Upside Potential and Strong Revenue Growth

BioLife Solutions, Inc. (NASDAQ: BLFS) is garnering significant attention in the healthcare sector, particularly within the niche of medical instruments and supplies. With a market capitalization of $1.22 billion, this..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds